Anna H. Wu
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (40)
Objective To evaluate the effects of ambient air pollution on rheumatoid arthritis (RA) incidence in a racially/ethnically diverse population. Methods This analysis included 42,152 California Multiethnic Cohort (MEC) participants, ages 65 or older (>70% African American and Latino adults) who were enrolled in the Fee‐for‐Service component of Medicare (2001‐2018). We employed multivariable Cox proportional hazards regression to examine the associations of time‐varying air pollutants based on spatiotemporal models with RA incidence (n=2,027) after adjusting for demographics, neighborhood socioeconomic status (nSES), smoking, work and other exposures. Results RA incidence increased with exposure to fine particulate matter (PM) with diameter ≤2.5 μm (PM 2.5 ) (hazard ratios (HR) [95% CI] per 2 μg/m 3 =1.20 [1.16‐1.23]) and nitrogen dioxide (NO 2 ) HR per 10 μg/m 3 =1.44 [1.35‐1.52]). Air pollutant levels and risk associations were higher in African American and Latino than in Japanese American and White adults (P heterogeneity <0.05). The RA‐PM 2.5 association was higher in men (1.23 [1.15‐1.32]) than in women (1.17 [1.12‐1.21] P heterogeneity =0.06). RA associations with PM 2.5 (and NO 2 ) did not differ by demographics, smoking, or other lifestyle factors but the HR associated with PM 2.5 was higher among those with high‐risk work (longest occupation in labor/craftsman work and exposed to ≥10 years in one or more of 13 industries) (1.29[1.18‐1.41]) than those without high‐risk work exposures (1.16 [1.12‐1.21] P heterogeneity =0.04). Conclusion Exposure to PM and gaseous pollution associates with increased RA incidence after age 65, particularly among African American and Latino adults. Further characterization of air pollution's contribution to racial and ethnic disparities in RA risk is warranted. image
Year:
2026
Background: Data on diet quality and pancreatic cancer are limited. We examined the relationship between diet quality, assessed by the Healthy Eating Index-2015 (HEI-2015), the Alternative Healthy Eating Index-2010 (AHEI-2010), the alternate Mediterranean Diet (aMED) score, the Dietary Approaches to Stop Hypertension (DASH) score and the energy-adjusted Dietary Inflammatory Index (E-DII), and pancreatic cancer incidence in the Multiethnic Cohort Study. Methods: Diet quality scores were calculated from a validated food frequency questionnaire administered at baseline. Cox models were used to calculate HR and 95% confidence intervals (CI) adjusted for age, sex, race/ethnicity, education, diabetes, family history of pancreatic cancer, physical activity, smoking variables, total energy intake, body mass index (BMI), and alcohol consumption. Stratified analyses by sex, race/ethnicity, smoking status, and BMI were conducted. Results: Over an average follow-up of 19.3 years, 1,779 incident pancreatic cancer cases were identified among 177,313 participants (average age of 60.2 years at baseline, 1993–1996). Overall, we did not observe associations between the dietary pattern scores and pancreatic cancer (aMED: 0.98; 95% CI, 0.83–1.16; HEI-2015: 1.03; 95% CI, 0.88–1.21; AHEI-2010: 1.03; 95% CI, 0.88–1.20; DASH: 0.92; 95% CI, 0.79–1.08; E-DII: 1.05; 95% CI, 0.89–1.23). An inverse association was observed with DASH for ever smokers (HR, 0.75; 0.61–0.93), but not for nonsmokers (HR, 1.05; 0.83–1.32). Conclusions: The DASH diet showed an inverse association with pancreatic cancer among ever smokers, but does not show a protective association overall. Impact: Modifiable measures are needed to reduce pancreatic cancer burden in these high-risk populations; our study adds to the discussion of the benefit of dietary changes.
Year:
2025
Supplementary Figure 3 shows scatter plots with the genetic association with folate on the x-axis and the genetic association with ovarian cancer on the y-axis, for (A) women with and (B) without endometriosis. The regression line for the inverse variance weighted Mendelian randomization method is shown.
Year:
2025
Supplementary Table 5 shows the results from the different Mendelian randomization methods investigating the association between genetically predicted folate and risk of ovarian cancer, by endometriosis status
Year:
2025
Background: Over 20 susceptibility single-nucleotide polymorphisms (SNP) have been identified for esophageal adenocarcinoma (EAC) and its precursor, Barrett esophagus (BE), explaining a small portion of heritability. Methods: Using genetic data from 4,323 BE and 4,116 EAC patients aggregated by international consortia including the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON), we conducted a comprehensive transcriptome-wide association study (TWAS) for BE/EAC, leveraging Genotype Tissue Expression (GTEx) gene-expression data from six tissue types of plausible relevance to EAC etiology: mucosa and muscularis from the esophagus, gastroesophageal (GE) junction, stomach, whole blood, and visceral adipose. Two analytical approaches were taken: standard TWAS using the predicted gene expression from local expression quantitative trait loci (eQTL), and set-based SKAT association using selected eQTLs that predict the gene expression. Results: Although the standard approach did not identify significant signals, the eQTL set–based approach identified eight novel associations, three of which were validated in independent external data (eQTL SNP sets for EXOC3 , ZNF641 , and HSP90AA1 ). Conclusions: This study identified novel genetic susceptibility loci for EAC and BE using an eQTL set–based genetic association approach. Impact: This study expanded the pool of genetic susceptibility loci for EAC and BE, suggesting the potential of the eQTL set–based genetic association approach as an alternative method for TWAS analysis.
Year:
2025
Supplementary Figure S5 shows the age-stratified calibration on 5- and 10-year absolute risks based on the PRS-enhanced model stratified by deciles of predicted risk in GERA European ancestry participants.
Year:
2025
Supplementary Figure S4 shows the family-history-stratified calibration on 5- and 10-year absolute risks based on the PRS-enhanced model stratified by deciles of predicted risk in GERA European ancestry participants.
Year:
2025
Background: Menstrual cycle characteristics—including age at menarche and cycle length— have been associated with ovarian cancer risk in White women. However, the associations between menstrual cycle characteristics and ovarian cancer risk among Black women have been sparsely studied. Methods: Using the Ovarian Cancer in Women of African Ancestry (OCWAA) Consortium that includes 1,024 Black and 2,910 White women diagnosed with epithelial ovarian cancer (EOC) and 2,325 Black and 7,549 White matched controls, we investigated associations between menstrual cycle characteristics (age at menarche, age at menstrual regularity, cycle length, and ever missing three periods) and EOC risk by race and menopausal status. Multivariable logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (CI). Results: Black women were more likely to be Conclusions: Earlier age at menarche and cycle irregularity are associated with increased EOC risk for White but not Black women. Impact: Associations between menstrual cycle characteristics and EOC risk were not uniform by race.
Year:
2025
Supplementary Table 3 shows the associations between folate intake (dietary, supplemental, total) and ovarian cancer by endometriosis status, and by histological subtype (endometrioid/clear cell cancers and high grade serous cancers).
Year:
2025
Supplementary Figure S2 shows the sex-stratified calibration on 5- and 10-year absolute risks based on the PRS-enhanced model stratified by deciles of predicted risk in GERA European ancestry participants.
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2022
Collaborators (153)
Li Hsu
Fred Hutchinson Cancer Research Center
Polly Newcomb
University of Washington
Rebecca C. Fitzgerald
Head of Academic Department
University of Cambridge
Marc Gunter
International Agency for Research on Cancer
Charlie Gourley
University of Edinburgh
Patricia Moorman
Professor
Duke University
Tabitha Harrison
Fred Hutchinson Cancer Research Center
Claire Palles
Associate Professor
University of Birmingham
Sue K. Park
Professor
Seoul National University College of Medicine
Konstantinos K. Tsilidis
-
Pushkar Inamdar
University of California, San Francisco
Lynn Rosenberg
Boston University
William Stohl
University of Southern California
Victor Moreno
Professor
University of Barcelona
Marina Evangelou
Senior Lecturer in Statistics
Imperial College London
Kathryn Terry
Co-Scientific Director
Boston Children's Hospital
Fränzel J.B. van Duijnhoven
Wageningen University & Research
Ines Gockel
University Hospital Leipzig
Xiaoyu Wang
University of Florida
Johannes Schumacher
Philipps-Universität Marburg
Beth Karlan
Vice Chair
University of California, Los Angeles
Wong-Ho Chow
Professor
The University of Texas MD Anderson Cancer Center
Susanna Larsson
Professor at Karolinska Institutet
Karolinska Institutet
Anna Jakubowska
Head
Pomeranian Medical University
Lynne Wilkens
Professor
University of Hawaii at Manoa
Juan Pablo Lewinger
Associate Professor
University of Southern California
Bo Qin
Associate Professor of Medicine
Rutgers Cancer Institute of New Jersey
John Baron
Professor
University of North Carolina
David Drew
Assistant Professor of Medicine
Massachusetts General Hospital
Puya Gharahkhani
Team Head, Associate Professor
QIMR Berghofer Medical Research Institute
Heather M Ochs-Balcom
Professor & Associate Chair
University at Buffalo
Matthew Wakefield
University of Melbourne
Markus Nöthen
Professor, Director
University Hospital Bonn
P. M. Webb
Group Leader
QIMR Berghofer Medical Research Institute
Martin Köbel
Associate Professor
University of Calgary
Estrid V. Hoegdall
University of Copenhagen
Jun Wu
University of California
Ulrike Peters
Fred Hutchinson Cancer Research Center
Jihyoun Jeon
University of Michigan
Song-Yi Park
-
Matthew Devall
Assistant Professor
University of Virginia
Sophia Harlid
Umea University
Eric Kawaguchi
Assistant Professor
University of Southern California
Paul Timpson
Co-Director ACRF (INCITe) Centre
Garvan Institute of Medical Research
Thomas Schmidt
Professor of Surgical Oncology / Chief Senior Consultant
Universitätsklinikum Bonn
James D Brenton
University of Cambridge
Julie R Palmer
Boston University School of Medicine
Jae-Weon Kim
Professor
Seoul National University Hospital
Sharon B Love
Methodology Lead of Trial Conduct Research
University College London
Thomas Vaughan
Professor
University of Washington
Cezary Cybulski
Pomeranian Medical University
Timothy Larson
Professor
University of Washington
Ian Tomlinson
University of Edinburgh
Lyndal Anderson
University of Western Sydney
Claus Høgdall
Professor in Clinical Gynecologic Oncology
University of Copenhagen
Elizabeth Platz
Professor
Johns Hopkins University
Lesley Anderson
University of Aberdeen
Lindsay J Collin
Assistant Professor
Emory University
Yingye Zheng
Fred Hutchinson Cancer Research Center
Mariana C. Stern
Professor
University of Southern California
John de Caestecker
Honorary Professor
University of Leicester
Anthony Gill
University of Sydney
Hans Prenen
Antwerp University Hospital
Paul James
Head of Adult Genetics
The Royal Melbourne Hospital Royal Park Campus
Parham Minoo
Associate Clinical Professor of Pathology
University of Calgary
Tim Bishop
University of Leeds
Prasad Iyer
Professor of Medicine and Chair
Mayo Clinic Arizona
Joellen Schilkdraut
Professor
Emory University
Michael Anglesio
Associate Professor
The University of British Columbia
Ramona Erber
W2-Professorin, Oberärztin
University of Regensburg
Nicholas Hawkins
Emeritus Professor
UNSW Sydney
Usha Menon
Professor of Gynaecological Oncology
University College London
Iona Cheng
University of California
Kristin Guertin
Assistant Professor
University of Connecticut
Elizabeth Hauser
Duke University
Evan Myers
Duke University
Richard Hayes
Professor of Population Health and Environmental Medicine
NYU School of Medicine
Daniel Stram
Professor
University of Southern California
Mingyang Song
Associate Professor
Harvard University
Carlos Caldas
Professor
Hebrew University of Jerusalem
Virginia Díez-Obrero
Vrije Universiteit Amsterdam
Jesper Lagergren
Professor and Chair of Upper Gastrointestinal Cancer and Honorary Consultant Surgeon
King’s College London
Sandra Orsulic
Professor
University of California, Los Angeles
David Whiteman
Deputy Director
QIMR Berghofer Medical Research Institute
Hongmei Nan
Professor
University of Indianapolis
Ian Campbell
Group Leader
Peter MacCallum Cancer Institute
Thomas Rösch
Chief of department, Prof. Dr
-
Stuart MacGregor
Professor
QIMR Berghofer Medical Research Institute
Emmanouil Bouras
Research associate
Imperial College London
Alicja Wolk
Professor of Nutritional Epidemiology
Karolinska Institutet
Jae-Hoon Kim
Yonsei University College of Medicine
John Potter
Professor
University of Washington
Bethany Van Guelpen
Umea University
Typhanye Penniman Dyer
Assistant Professor
University of Maryland at College Park
Li Li
University of Virginia
Iris Lansdorp-Vogelaar
Associate Professor
Erasmus University Medical Center
C Blake Gilks
-
Peter Fasching
-
Francesmary Modugno
University of Pittsburgh
Andrea Burnett-Hartman
Epidemiologist Program Director
Fred Hutchinson Cancer Research Center
Kylie-Ann Mallitt
Senior Lecturer in Biostatistics
University of Sydney
Philip Crowe
Professor Surgery
University of New South Wales
Andrea Gsur
Medical University of Vienna
K Sundfeldt
Professor/Consultant
University of Gothenburg, Sahlgrenska Academy
Tomasz Huzarski
Pomeranian Medical University
Byoung-Gie Kim
Sungkyunkwan University School of Medicine
Dane Cheasley
Senior Research Fellow
University in Western Australia
Loic Le Marchand
Professor
University of Hawaii
Matthias Reeh
University Medical Center Hamburg-Eppendorf
Edward A. Ruiz-Narváez
Associate Professor
University of Michigan School of Public Health
Elom K Aglago
Imperial College London
Jennifer Anne Doherty
Professor
University of Utah
David Conti
Professor
Colorado School of Public Health
W. James Gauderman
professor
University of Southern California
Paul Pharoah
Professor of Cancer Epidemiology
Cedars-Sinai Medical Center
Marino Venerito
-
Graham Casey
University of Virginia
Catherine Tangen
Fred Hutchinson Cancer Research Center
Paul Moayyedi
Audrey Campbell Chair of Ulcerative Colitis Research
McMaster University
Kala Visvanathan
Professor
Johns Hopkins University
Kylie L Gorringe
Group Leader
Peter MacCallum Cancer Institute
Salma Shariff‐Marco
Professor
University of California, San Francisco
Jan Lubiński
Head of Dept
Pomeranian Medical University
Janusz Jankowski
Professor
University College London
Veronica Setiawan
Associate Professor
University of Southern California
Daniel D. Buchanan
Senior Research Fellow
University of Melbourne
Aleksandra Gentry-Maharaj
University College London
Geoffrey Liu
The M. Qasim Choksi Chair in Lung Cancer Translational Research
University of Toronto
Annika Lindblom
Karolinska Institutet
James Hebert
Professor/ Director
University of South Carolina
Beate Ritz
Professor
University of California
David G. Huntsman
The University of British Columbia
Janusz Menkiszak
Head of the University Clinic
Pomeranian Medical University
Stephen Gruber
Professor
City Of Hope National Medical Center
Jochen Hampe
Scientific Speaker
Technische Universität Dresden
Clare Scott
Walter and Eliza Hall Institute of Medical Research
Mindy DeRouen
Assistant Professor
New Mexico State University
Anshul Kundaje
Associate Professor
Stanford University
Elisa Bandera
Chief
Rutgers Cancer Institute of New Jersey
Susan Ramus
Professor of Molecular Oncology
University of New South Wales
Mark Jenkins
University of Melbourne
Peter T. Campbell
Professor
Albert Einstein College of Medicine
Graham Giles
Head of Research
-
Suzanne Dixon-Suen
Deakin University
Paul Cohen
University of Western Australia
Michael Hoffmeister
Professor of Epidemiology, Group leader, Deputy divison head
German Cancer Research Center (DKFZ)
Aline Talhouk
Assistant Professor
The University of British Columbia
Volker Arndt
Group leader
Deutsches Krebsforschungszentrum
Charlotte Joslin
University of Illinois Chicago (UIC)
Elizabeth Barry
Associate Professor
Dartmouth College Geisel School of Medicine
Pavel Vodička
senior researcher
Charles University
Jennifer Ose
Professorin (W2)
Hochschule Hannover
David Lawson Morris
Professor of Surgery
University of New South Wales
Make your next move.
Prepare your application
Review drafts before you send them.